MIRA Pharmaceuticals, Inc.

NasdaqCM:MIRA Stock Report

Market Cap: US$18.2m

MIRA Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:MIRA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
28 Aug 24SellUS$392,000Bayshore TrustCompany200,000US$1.96
21 May 24BuyUS$8,176Erez AminovIndividual8,700US$1.03

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of MIRA?
Owner TypeNumber of SharesOwnership Percentage
Institutions830,3025.01%
Private Companies2,540,27015.3%
Individual Insiders3,451,20020.8%
General Public9,739,08058.8%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 12%.

Top Shareholders

Top 25 shareholders own 41.19% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
15.3%
Bayshore Trust
2,540,270US$2.8m-7.3%no data
6.41%
Erez Aminov
1,061,200US$1.2m184%no data
4.11%
William Nellis
680,000US$748.0k0%no data
4.05%
Brian McNulty
670,000US$737.0k0%no data
4.05%
Samuel Duffey
670,000US$737.0k0%no data
2.21%
Cross Staff Investments, Inc.
365,901US$402.5k-4.56%0.29%
1.21%
Adam Kaplin
200,000US$220.0k0%no data
0.7%
Geode Capital Management, LLC
115,914US$127.5k1,090%no data
0.54%
Suncoast Equity Management, LLC
90,000US$99.0k125%0.01%
0.3%
LPL Financial Corporation, Asset Management Arm
50,000US$55.0k0%no data
0.3%
Bradley Kroenig
50,000US$55.0k0%no data
0.25%
Schonfeld Strategic Advisors LLC
41,900US$46.1k0%no data
0.25%
Millennium Management LLC
40,725US$44.8k0%no data
0.24%
David Vorhoff
40,000US$44.0k0%no data
0.24%
Hugh McColl
40,000US$44.0k0%no data
0.19%
Avantax Planning Partners, Inc.
32,000US$35.2k-73.1%no data
0.12%
Northern Trust Global Investments
20,124US$22.1k-1.61%no data
0.12%
First American Bank Corporation, Asset Management Arm
20,000US$22.0k0%no data
0.12%
Talhia Tuck
20,000US$22.0k0%no data
0.12%
George Cappy
20,000US$22.0k0%no data
0.11%
Praetorian Wealth Management, Inc.
17,500US$19.2k-36.4%no data
0.074%
Jane Street Group, LLC, Asset Management Arm
12,186US$13.4k0%no data
0.072%
Two Sigma Securities, LLC, Asset Management Arm
11,964US$13.2k-33%no data
0.06%
Cary Street Partners Investment Advisory LLC
10,000US$11.0k0%no data
0.012%
Steward Partners Investment Advisory, LLC
2,000US$2.2k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 15:26
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

MIRA Pharmaceuticals, Inc. is covered by 3 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Edward WooAscendiant Capital Markets LLC
Karen SterlingKingswood Capital
Bradley SorensenZacks Small-Cap Research